Read + Share
Amedeo Smart
Independent Medical Education
Tahseen S, vanDeun A, de Jong BC, Decroo T, et al. Second-line injectable drugs for rifampicin-resistant tuberculosis: better the devil we know? J Antimicrob Chemother 2020 Dec 1. pii: 6015577. doi: 10.1093.PMID: 33258921
Email
LinkedIn
Facebook
Twitter
Privacy Policy